You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
Novo Nordisk Faces Antitrust Lawsuit Over Alleged Monopoly on Victoza Diabetes Medication Novo Nordisk has been sued for allegedly monopolizing the diabetes drug Victoza, with claims that the company engaged in anticompetitive practices to maintain exclusive control over the market. The lawsuit highlights co... Read the full IIPLA article: https://iipla.org/news/novo-nordisk-faces-antitrust-lawsuit-over-alleged-monopoly-on-victoza-diabetes-medication